34122447|t|Sorafenib Modulates the LPS- and Abeta-Induced Neuroinflammatory Response in Cells, Wild-Type Mice, and 5xFAD Mice.
34122447|a|Sorafenib is FDA-approved for the treatment of primary kidney or liver cancer, but its ability to inhibit many types of kinases suggests it may have potential for treating other diseases. Here, the effects of sorafenib on neuroinflammatory responses in vitro and in vivo and the underlying mechanisms were assessed. Sorafenib reduced the induction of mRNA levels of the proinflammatory cytokines COX-2 and IL-1beta by LPS in BV2 microglial cells, but in primary astrocytes, only COX-2 mRNA levels were altered by sorafenib. Interestingly, sorafenib altered the LPS-mediated neuroinflammatory response in BV2 microglial cells by modulating AKT/P38-linked STAT3/NF-kB signaling pathways. In LPS-stimulated wild-type mice, sorafenib administration suppressed microglial/astroglial kinetics and morphological changes and COX-2 mRNA levels by decreasing AKT phosphorylation in the brain. In 5xFAD mice (an Alzheimer's disease model), sorafenib treatment daily for 3 days significantly reduced astrogliosis but not microgliosis. Thus, sorafenib may have therapeutic potential for suppressing neuroinflammatory responses in the brain.
34122447	0	9	Sorafenib	Chemical	MESH:D000077157
34122447	24	27	LPS	Chemical	MESH:D008070
34122447	33	38	Abeta	Gene	14961
34122447	47	64	Neuroinflammatory	Disease	MESH:D000090862
34122447	94	98	Mice	Species	10090
34122447	110	114	Mice	Species	10090
34122447	116	125	Sorafenib	Chemical	MESH:D000077157
34122447	171	193	kidney or liver cancer	Disease	MESH:D007680
34122447	325	334	sorafenib	Chemical	MESH:D000077157
34122447	338	355	neuroinflammatory	Disease	MESH:D000090862
34122447	432	441	Sorafenib	Chemical	MESH:D000077157
34122447	512	517	COX-2	Gene	17709
34122447	522	530	IL-1beta	Gene	16176
34122447	534	537	LPS	Chemical	MESH:D008070
34122447	541	544	BV2	CellLine	CVCL:0182
34122447	595	600	COX-2	Gene	17709
34122447	629	638	sorafenib	Chemical	MESH:D000077157
34122447	655	664	sorafenib	Chemical	MESH:D000077157
34122447	677	680	LPS	Chemical	MESH:D008070
34122447	690	707	neuroinflammatory	Disease	MESH:D000090862
34122447	720	723	BV2	CellLine	CVCL:0182
34122447	755	758	AKT	Gene	11651
34122447	759	762	P38	Gene	26416
34122447	770	775	STAT3	Gene	20848
34122447	805	808	LPS	Chemical	MESH:D008070
34122447	830	834	mice	Species	10090
34122447	836	845	sorafenib	Chemical	MESH:D000077157
34122447	933	938	COX-2	Gene	17709
34122447	965	968	AKT	Gene	11651
34122447	1008	1012	mice	Species	10090
34122447	1017	1036	Alzheimer's disease	Disease	MESH:D000544
34122447	1045	1054	sorafenib	Chemical	MESH:D000077157
34122447	1104	1116	astrogliosis	Disease	MESH:D005911
34122447	1125	1137	microgliosis	Disease	
34122447	1145	1154	sorafenib	Chemical	MESH:D000077157
34122447	1202	1219	neuroinflammatory	Disease	MESH:D000090862
34122447	Positive_Correlation	MESH:D008070	MESH:D000090862
34122447	Positive_Correlation	MESH:D000090862	14961
34122447	Negative_Correlation	MESH:D000077157	16176
34122447	Positive_Correlation	MESH:D008070	16176
34122447	Negative_Correlation	MESH:D000077157	MESH:D000090862
34122447	Negative_Correlation	MESH:D000077157	MESH:D005911
34122447	Negative_Correlation	MESH:D000077157	MESH:D007680
34122447	Association	MESH:D000077157	14961
34122447	Association	MESH:D000077157	20848
34122447	Association	MESH:D000077157	11651
34122447	Association	MESH:D008070	20848
34122447	Association	MESH:D008070	26416
34122447	Association	MESH:D000090862	20848
34122447	Association	MESH:D000090862	11651
34122447	Association	MESH:D000090862	26416
34122447	Association	11651	17709
34122447	Negative_Correlation	MESH:D000077157	17709
34122447	Positive_Correlation	MESH:D008070	17709
34122447	Association	MESH:D000077157	26416
34122447	Association	MESH:D000077157	MESH:D008070

